The Burden of Occupational Cancer in Great Britain RR595 Technical Annex 5: Bladder Cancer
Total Page:16
File Type:pdf, Size:1020Kb
Health and Safety Executive The burden of occupational cancer in Great Britain Technical Annex 5: Bladder cancer Prepared by Imperial College London and the Health and Safety Laboratory for the Health and Safety Executive 2007 RR595 Technical Annex 5 Health and Safety Executive The burden of occupational cancer in Great Britain Technical Annex 5: Bladder cancer Lesley Rushton & Sally Hutchings Imperial College London Department of Epidemiology and Public Health Faculty of Medicine St Mary’s Campus Norfolk Place London W2 1PG Terry Brown Health and Safety Laboratory Harpur Hill Buxton SK17 9JN The aim of this project was to produce an updated estimate of the current burden of occupational cancer specifically for Great Britain. The primary measure of the burden of cancer used was the attributable fraction (AF), ie the proportion of cases that would not have occurred in the absence of exposure. Data on the risk of the disease due to the exposures of interest, taking into account confounding factors and overlapping exposures, were combined with data on the proportion of the target population exposed over the period in which relevant exposure occurred. Estimation was carried out for carcinogenic agents or exposure circumstances that were classified by the International Agency for Research on Cancer (IARC) as Group 1 or 2A carcinogens with strong or suggestive human evidence. Estimation was carried out for 2004 for mortality and 2003 for cancer incidence for cancer of the bladder, leukaemia, cancer of the lung, mesothelioma, non melanoma skin cancer (NMSC), and sinonasal cancer. The proportion of cancer deaths in 2004 attributable to occupation was estimated to be 8.0% in men and 1.5% in women with an overall estimate of 4.9% for men plus women. Estimated numbers of deaths attributable to occupation were 6,259 for men and 1,058 for women giving a total of 7,317. The total number of cancer registrations in 2003 attributable to occupational causes was 13,338 for men plus women. Asbestos contributed the largest numbers of deaths and registrations (mesothelioma and lung cancer), followed by mineral oils (mainly NMSC), solar radiation (NMSC), silica (lung cancer) and diesel engine exhaust (lung and bladder cancer). Large numbers of workers were potentially exposed to several carcinogenic agents over the risk exposure periods, particularly in the construction industry, as farmers or as other agricultural workers, and as workers in manufacture of machinery and other equipment, manufacture of wood products, land transport, metal working, painting, welding and textiles. There are several sources of uncertainty in the estimates, including exclusion of other potential carcinogenic agents, potentially inaccurate or approximate data and methodological issues. On balance, the estimates are likely to be a conservative estimate of the true risk. Future work will address estimation for the remaining cancers that have yet to be examined, together with development of methodology for predicting future estimates of the occupational cancers due to more recent exposures. This report and the work it describes were funded by the Health and Safety Executive (HSE). Its contents, including any opinions and/or conclusions expressed, are those of the authors alone and do not necessarily reflect HSE policy. HSE Books © Crown copyright 2007 First published 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means (electronic, mechanical, photocopying, recording or otherwise) without the prior written permission of the copyright owner. Applications for reproduction should be made in writing to: Licensing Division, Her Majesty’s Stationery Office, St Clements House, 216 Colegate, Norwich NR3 1BQ or by email to hmsolicensing@cabinetoffice.x.gsi.gov.uk ii ACKNOWLEDGEMENTS We would like to thank Damien McElvenny for initiating the project and Gareth Evans for his management role. Andy Darnton from the HSE was responsible for the work on mesothelioma. The contributions to the project and advice received from many other HSE and HSL staff is gratefully acknowledged. Two workshops were held during the project bringing together experts from the UK and around the world. We would like to thank all those who participated and have continued to give advice and comment on the project. iii iv CONTENTS Acknowledgements iii 1. Incidence and Trends 1 2. Overview of Aetiology 5 2.1. Introduction 5 2.2. Exposures 9 3. Attributable Fraction Estimation 18 3.1. General Considerations 18 3.2. Mineral oils 21 3.3. Aromatic amines 24 3.4. Painters 28 3.5. Rubber industry 29 3.6. Polycyclic aromatic hydrocarbons (PAH) 30 3.7. Diesel engine exhaust 34 3.8. Hairdressers and barbers 38 4. Overall attributable fraction 40 4.1 Comparison of exposure AFs 40 4.2 Exposure Map 40 4.3 Overall AF 42 4.4 Summary of results 43 4.5 Exposures in construction 44 4.6 Higher versus lower level exposures 45 5. References 47 6. Annexes 57 Annex 1 57 Annex 2 59 v vi 1. INCIDENCE AND TRENDS Bladder cancer (ICD-10 C67; ICD-9 188) refers to any of several types of malignant growths of the urinary bladder. About 90-95% of bladder cancers are transitional cell carcinomas; the remainder are squamous cell carcinomas and adenocarcinomas (Quinn et al., 2001). Seventy-five per cent are superficial, limited to the mucose, sub-mucosa or lamina propria (de Braud et al., 2002); the rest are invasive into the muscle. Every year in the UK, almost 10,200 people are diagnosed with bladder cancer, causing more than 4,800 deaths each year. In the UK and Ireland, bladder cancer accounted for around 1 in 20 of all cancer registrations and 1 in 30 cancer deaths in the 1990s (Quinn et al., 2005). Bladder cancer is the 5th most commonly diagnosed cancer for all population groups combined (21.0/100,000) (Clapp et al., 2005) and is the 4th commonest cancer affecting men and the 10th commonest cancer affecting women (excluding non melanoma skin cancer)(Cancer Research UK, 2002). In Great Britain, the age-standardised incidence rates rose throughout the 1970s and 1980s to reach a peak in the late 1980s of around 31 per 100,000 males and 9 per 100,000 females. Over the last 2 decades, mortality has shown downward trends in several western European countries (albeit 10-15 years later than similar trends in the US), but is still increasing in some eastern European countries (Pelucchi et al., 2006). The annual number of deaths for males and females in the UK and its constituent countries, together with the rates for the year 2004 are shown in Table 1. Incidence and mortality rates in women in England and Wales were high by international standards. England had the highest number of deaths, but Scotland had the highest rates (per 100,000 population). Within the UK, geographical patterns in incidence are obscured by known differences among counties and regions of England in the classification and registration of bladder tumours. Mortality in both males and females was higher than average in Scotland and in a band across the north of England and noticeably lower in Northern Ireland and Ireland (Quinn et al., 2005). Occupational exposure to chemicals, predominantly in male workers in the dye and rubber industries, may explain some of the observed geographical patterns (Quinn et al., 2005). Table 1: Number of deaths and mortality rates of bladder cancer, UK, 2004 England Wales Scotland N.Ireland UK Number of Deaths Males 2,688 150 275 49 3,162 Females 1,377 84 168 25 1,654 Persons 4,065 234 443 74 4,816 Crude rate per 100,000 population Males 11.0 10.5 11.3 5.9 10.8 Females 5.4 5.5 6.4 2.9 5.4 Persons 8.1 7.9 8.7 4.3 8.1 Age-standardised rate (European) per 100,000 population Males 8.5 (8.2,8.8) 7.3 (6.2,8.5) 9.0 (7.9,10.0) 5.6 (4.0,7.2) 8.4 (8.1,8.7) Females 2.9 (2.7,3.0) 2.5 (2.0,3.0) 3.4 (2.9,4.0) 1.8 (1.1,2.5) 2.9 (2.7,3.0) Persons 5.2 (5.0,5..3) 4.4 (3.9,5.0) 5.7 (5.2,6.2) 3.3 (2.6,4.1) 5.1 (5.0,5.3) Source: (Cancer Research UK, 2002) 1 In most European countries, including England and Wales, bladder cancer is at least three times less frequent in women than in men (worldwide ratio is about 3.5:1), which has been seen as an indication for an occupational origin (Lilienfeld and Lilienfeld, 1980; Parkin and Muir, 1992). Whilst female rates have changed little from around 3.3 in the early 1970s to 2.9 in 2004, the male rates have shown a consistent fall since 1992, from 12.2 to 8.4 per 100,000 in the year 2004, a fall of around 30%. The male:female ratio of age-standardised rates has consequently changed, from 4.0:1 in 1975 to 1.9:1 in 2004 (Cancer Research UK, 2002). The higher incidence among men can be attributed, in part, to the differences in smoking habits, with occupational exposures the second most important risk factor in men. Few cases of bladder cancer occur under the age of 50, but thereafter the rates rise with age to reach a peak in the oldest age groups. When mortality rates are examined by age, the largest falls in mortality have been in the younger (50-59) age group and the all-age rate for women masked substantial changes within different age-groups.